Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2002
09/17/2002CA2007332C Use of a glycine b partial agonist as an antipsychotic
09/16/2002CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes
09/12/2002WO2002070742A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
09/12/2002WO2002070741A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
09/12/2002WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them
09/12/2002WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/12/2002WO2002070676A2 Use of protein histidine phosphatase
09/12/2002WO2002070669A2 Secreted proteins
09/12/2002WO2002070646A2 Matrix stabilized enzyme crystals and methods of use
09/12/2002WO2002070563A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070562A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070561A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070560A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070559A2 Nuclear hormone receptor ligand binding domains
09/12/2002WO2002070558A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070557A2 Nuclear hormone receptor ligand binding domain
09/12/2002WO2002070551A2 Neuritogenic compound and uses thereof
09/12/2002WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto
09/12/2002WO2002070534A1 C2, 8-disubstituted adenosine derivatives and their different uses
09/12/2002WO2002070532A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
09/12/2002WO2002070524A2 N-but-3-enyl norbuprenorphine and its use as analgesic
09/12/2002WO2002070523A1 Modulators of chemokine receptor activity
09/12/2002WO2002070522A1 Novel 2,5-diazabicyclo[2.2.1]heptane derivatives
09/12/2002WO2002070515A2 Chromane derivatives, process for their preparation and their use as antitumor agents
09/12/2002WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002WO2002070502A1 Dimeric isoflavones
09/12/2002WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
09/12/2002WO2002070496A1 Nitric oxide donors based on metallic centres
09/12/2002WO2002070492A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
09/12/2002WO2002070490A1 Agonists of beta-adrenoceptors
09/12/2002WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
09/12/2002WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
09/12/2002WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators
09/12/2002WO2002070473A2 Carboxamide derivatives as therapeutic agents
09/12/2002WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
09/12/2002WO2002070459A1 Novel amino dicarboxylic acid derivatives
09/12/2002WO2002070457A1 Inhibitor of monoamine uptake
09/12/2002WO2002070070A2 Compositions having improved bioavailability of eletriptan
09/12/2002WO2002069993A1 Pharmaceutical composition made of cannabis extracts
09/12/2002WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies
09/12/2002WO2002069976A2 Use of ovarian hormone for increasing neural stem cell number
09/12/2002WO2002069975A1 Use of estrogen to induce neural stem cell increase
09/12/2002WO2002069972A2 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia
09/12/2002WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
09/12/2002WO2002069965A1 Benzimidazole derivatives as therapeutic agents
09/12/2002WO2002069958A1 Thiocyanate ions for preventing and treating bse and similar animal and human diseases
09/12/2002WO2002069951A2 Composition containing a nefazonoid such as nefazodone and a serotonin-inhibitor such as fluoxetine
09/12/2002WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
09/12/2002WO2002069946A2 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
09/12/2002WO2002069941A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
09/12/2002WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/12/2002WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
09/12/2002WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof
09/12/2002WO2002069893A2 Treatment of neurological disease
09/12/2002WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof
09/12/2002WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto
09/12/2002WO2002044187A3 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
09/12/2002WO2002028859A3 Condensed pyridoindole derivatives
09/12/2002WO2002014369A3 Human kininogen d5 domain polypeptides and their use
09/12/2002WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line
09/12/2002WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
09/12/2002WO2001089530A3 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator
09/12/2002WO2001089520A3 Dehydroascorbic acid formulations and uses thereof
09/12/2002WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses
09/12/2002WO2001074339A3 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
09/12/2002WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
09/12/2002WO2001047497A3 Controlled release pharmaceutical composition containing tramadol hydrochloride
09/12/2002WO2001045722A9 Somnogenic activity of non-pathogenic lactic acid bacteria
09/12/2002WO2001041768A9 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments
09/12/2002WO2001041752A3 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain
09/12/2002WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
09/12/2002WO2001028539A3 Agent for treating cephalic pain
09/12/2002WO2001015700A9 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO
09/12/2002WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes
09/12/2002US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
09/12/2002US20020129385 Medthods for improving long-term memory storage and retrieval
09/12/2002US20020128591 Transdermal electrotransport device and method for manufacturing same
09/12/2002US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/12/2002US20020128477 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
09/12/2002US20020128475 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders
09/12/2002US20020128471 Useful for treating cellular hyperproliferation
09/12/2002US20020128447 Pharmaceutical composition containing IL-10
09/12/2002US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases
09/12/2002US20020128319 Abeta 42 lowering agents
09/12/2002US20020128316 Neuroprotective composition and uses thereof
09/12/2002US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction
09/12/2002US20020128302 Use of a CB1 receptor antagonist for the preparation of drugs useful in the treatment of appetency disorders, such as obesity associated with non-insulin- dependent diabetes and drug dependence
09/12/2002US20020128288 Useful in the treatment of chronic and acute pain.
09/12/2002US20020128286 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
09/12/2002US20020128285 Topical delivery of a local anesthetic
09/12/2002US20020128284 Tropane-derivatives, their preparation and use
09/12/2002US20020128279 Potassium channel blocking agents
09/12/2002US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food
09/12/2002US20020128277 Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases
09/12/2002US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists
09/12/2002US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone
09/12/2002US20020128265 CRF receptor antagonists and methods relating thereto
09/12/2002US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders.
09/12/2002US20020128261 Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives
1 ... 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 ... 1833